Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05685368 · ClinicalTrials.gov registry record · Phase 1
Acceptance and Commitment Therapy for Adolescents and Young Adults With Sickle Cell Disease
A Phase 1 study, sponsored by Children's Hospital Los Angeles.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 66
- Enrollment target
NCT05685368 is a Phase 1 study that is actively recruiting participants, run by Children's Hospital Los Angeles. The registered enrollment target is 66 participants.
The verdict
NCT05685368, a Phase 1 study, is actively recruiting participants, sponsored by Children's Hospital Los Angeles.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 66 participants
- Enrollment target
Study Summary
The current study seeks to build on previous research that demonstrates the efficacy of Acceptance and Commitment Therapy in combating stigma by investigating the feasibility and acceptability of a protocol to support Black adolescents and young adults in coping with race related stress. The study will consist of a small, purposeful, non-randomized sample (N = 30) of clients enrolled into a 10-session Acceptance and Commitment Therapy group. The group will be offered as part of regular clinical care at the Division of Adolescent and Young Adult Medicine. Three consecutive groups will be run with approximately 8-10 participants in each group over the next year.
Interventions
- BEHAVIORAL ACT for SCD
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2025-04-01 |
| Est. Completion | 2029-06-30 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05685368
The ClinicalTrials.gov registry entry for NCT05685368 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 66 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital Los Angeles, which has 119 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ACT for SCD is the first listed.
NCT05685368 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05685368 about?
NCT05685368 is a clinical study titled "Acceptance and Commitment Therapy for Adolescents and Young Adults With Sickle Cell Disease". The current study seeks to build on previous research that demonstrates the efficacy of Acceptance and Commitment Therapy in combating stigma by investigating the feasibility and acceptability of a protocol to support Black adolescents and young adults in coping with race related stress. The study w...
What is the current status of trial NCT05685368?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 66 participants. The study started on 2025-04-01. Estimated completion is 2029-06-30.
What interventions are being tested in trial NCT05685368?
The interventions under investigation include: ACT for SCD (BEHAVIORAL).
Who is sponsoring clinical trial NCT05685368?
This trial is sponsored by Children's Hospital Los Angeles, which has 119 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.